Top Page
SciDev Ltd
(Sydney:SDV)
SciDev Ltd (SDV) vs. iShares MSCI Australia ETF (EWA)
SciDev Ltd Business Overview & Revenue Model
SciDev Ltd Financial Statement Overview
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 103.50M | 103.50M | 109.09M | 89.72M | 55.60M | 42.52M |
| Gross Profit | 33.39M | 33.39M | 33.97M | 6.83M | 3.69M | 1.37M |
| EBITDA | 5.91M | 5.91M | 7.65M | 4.11M | 1.13M | 1.88M |
| Net Income | -878.00K | -878.00K | 2.17M | -339.00K | -616.00K | 3.45M |
Balance Sheet | ||||||
| Total Assets | 75.23M | 75.23M | 72.01M | 67.37M | 71.16M | 56.15M |
| Cash, Cash Equivalents and Short-Term Investments | 9.68M | 9.68M | 9.43M | 7.73M | 14.06M | 7.01M |
| Total Debt | 6.26M | 6.26M | 5.13M | 3.48M | 2.90M | 5.13M |
| Total Liabilities | 25.18M | 25.18M | 21.78M | 19.35M | 22.32M | 24.54M |
| Stockholders Equity | 50.05M | 50.05M | 50.24M | 48.02M | 48.84M | 31.61M |
Cash Flow | ||||||
| Free Cash Flow | 785.00K | 785.00K | 4.48M | 522.00K | -3.83M | -1.92M |
| Operating Cash Flow | 2.87M | 2.87M | 6.48M | 4.81M | -1.31M | -1.32M |
| Investing Cash Flow | -2.35M | -2.35M | -3.71M | -8.39M | -6.65M | -2.49M |
| Financing Cash Flow | -390.00K | -390.00K | -1.06M | -2.83M | 14.99M | 6.34M |
SciDev Ltd Technical Analysis
SciDev Ltd Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
55 Neutral | AU$40.53M | -5.36 | -67.76% | ― | 7.08% | 33.70% | |
53 Neutral | AU$82.69M | -94.57 | -1.75% | ― | -5.37% | -140.00% | |
52 Neutral | AU$114.26M | -5.29 | -22.28% | ― | 16.47% | 29.53% | |
48 Neutral | AU$18.91M | -6.93 | -63.81% | ― | ― | 52.66% | |
37 Underperform | AU$10.80M | -2.78 | -263.52% | ― | -32.85% | 28.00% | |
28 Underperform | AU$27.34M | -2.97 | -869.14% | ― | 340.27% | 19.44% |
SciDev Ltd Corporate Events
SciDev Ltd announced the results of its 2025 Annual General Meeting, where three out of four resolutions were passed, including the re-election of Mr. Jon Gourlay and the election of Mr. Johannes Risseeuw as Directors. However, the resolution for an additional 10% placement capacity was not approved. This outcome may influence the company’s strategic decisions and shareholder relations moving forward.
In its 2025 AGM, SciDev Ltd reported a stable financial performance for FY25, with revenues of A$103.4 million and an underlying EBITDA of A$7.1 million, despite market volatility. The company achieved significant progress in its strategic objectives, particularly in its Energy Services segment, which saw increased sales and market share, notably re-entering the Permian Basin with a $10 million supply agreement. The Process Chemistry segment overcame challenges in the mining sector by securing new business in mineral sands and construction, while the Water Technologies segment expanded its global footprint and secured a $19.5 million contract for a groundwater treatment plant. These developments underscore SciDev’s strategic investments and market positioning, enhancing its growth prospects and stakeholder value.
SciDev Ltd has strategically positioned itself to address significant environmental challenges, focusing on PFAS remediation, industrial water treatment, and energy sector water management. The company has strengthened its foundation in FY25 by improving its operating rhythm and defining a sharper strategic focus, ensuring it remains at the forefront of emerging environmental investment cycles. The Board emphasizes governance priorities such as capital discipline and aligning investments with proven opportunities to build a sustainable and reliable company.
SciDev Ltd has secured a $19.5 million contract for the design and construction of a groundwater treatment plant as part of the Rum Jungle Rehabilitation Project in Australia. This project, a significant environmental remediation effort, aims to treat contaminated groundwater from legacy uranium mining, benefiting the local community and environment. The contract underscores SciDev’s capability in delivering specialized water treatment solutions and enhances its position in the market for large-scale mine rehabilitation.
SciDev Ltd has announced the appointment of Todd Scott as the new Chief Financial Officer, effective immediately. With over 20 years of experience in finance and strategic execution across various sectors, Scott is expected to enhance SciDev’s leadership and support its growth strategy. The outgoing CFO, Anna Hooper, is recognized for her significant contributions to the company’s growth and financial management over the past four years.
SciDev Ltd has announced a new issuance of 49,556 fully paid ordinary securities to be quoted on the Australian Securities Exchange (ASX) under the code SDV, effective from October 21, 2025. This move is part of the company’s ongoing efforts to enhance its market presence and provide more liquidity for its stakeholders, reflecting a strategic initiative to bolster its financial standing and operational capabilities.
SciDev Ltd has announced its 2025 Annual General Meeting (AGM) scheduled for November 20, 2025, in Sydney. The meeting will address several key resolutions, including the adoption of the Remuneration Report, the election and re-election of directors, and the approval of an additional 10% placement capacity. These resolutions are significant for SciDev’s governance and strategic direction, potentially impacting shareholder value and the company’s market positioning.
SciDev Ltd has announced that its 2025 Annual General Meeting (AGM) will be held on November 20, 2025, where the re-election of Directors will be considered. The deadline for director nominations is October 2, 2025. This announcement reflects SciDev’s ongoing corporate governance practices and may influence its strategic direction and leadership structure, impacting stakeholders and potentially affecting its market positioning.
SciDev Ltd has announced a blueprint for growth as part of its FY25 investor presentation, highlighting its commitment to solving complex water problems through innovative solutions. The company has treated over 8 billion litres of PFAS-contaminated water and serviced 380 wells with its CatChek technology, emphasizing its significant impact on improving operational and environmental outcomes across various heavy industries. This strategic focus is expected to strengthen SciDev’s market position and offer substantial benefits to its stakeholders.